WHO ICTRP trial

Study of siddha drug Vaatha choornam (internal) and Vaatha mega narayana ennai…

CTRI/2017/05/008594 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2017/05/008594
Public title Study of siddha drug Vaatha choornam (internal) and Vaatha mega narayana ennai (External) in the treatment of Rheumatoid arthritis(joint pain) (Valiazhal keelvayu)
Scientific title Preclinical and clinical study of siddha drugs Vaatha chooranam (internal) and Vaatha mega narayana ennai (external) in the treatment of Vali Azhal keel vayu(Rheumatoid Arthritis)
Primary sponsor Ayothidoss pandithar hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: null- Vali Azhal Keel Vayu (Rheumatoid arthritis)
Interventions Intervention1: Muddakku vatha choornam (internal) and vatha mega Narayana ennai(external): 2 gm of Muddakku vatha choornam administered orally twice a day with honey for a period of 48 days. Control Intervention1: NIL: NIL
Registration date May 19, 2017
Target size 40
Secondary IDs Nil
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations